Transient Decrease in Pediatric Bronchiolitis Hospitalizations Seen During Pandemic

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

MONDAY, Oct. 30, 2023 -- During the COVID-19 pandemic era, pediatric bronchiolitis hospitalizations decreased transiently, then increased, according to a study published online Oct. 26 in JAMA Network Open.

Kailey A. Remien, D.O., from Akron Children's Hospital in Ohio, and colleagues conducted a retrospective cross-sectional study using data from 41 U.S. children's hospitals in the Pediatric Health Information System database to analyze changes in patterns of bronchiolitis admissions for patients aged younger than 2 years admitted between July 1, 2010, and June 30, 2023. Data were included for 400,801 bronchiolitis admissions among 349,609 patients.

The researchers found that during the prepandemic era, hospitalizations increased gradually, then decreased 69.2 percent in the 2020 to 2021 season and increased 75.3 percent in the 2022 to 2023 season. Compared with the prepandemic era, patients in the pandemic era were older (median, 7 versus 6 months). From the prepandemic era to the pandemic era, there was a significant increase seen in intensive care unit admissions from 32.2 to 36.7 percent. During the pandemic era, the seasonality of bronchiolitis admissions changed, with admissions peaking in August 2021 (actual versus forecasted: 5,036 versus 943) and November 2022 (actual versus forecasted: 10,120 versus 5,268). In sensitivity analyses excluding children with complex chronic conditions and excluding repeat admissions, these findings were unchanged.

"The seasonality of bronchiolitis admissions does not yet appear to be stable, and U.S. hospitals should prepare for the possibility of atypical timing again in 2023," the authors write.

Abstract/Full Text

Posted : 2023-10-31 13:55

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords